Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604550 · ClinicalTrials.gov registry record · Phase 4
Anterior Cruciate Ligament Pain Study
A Phase 4 study of Anterior Cruciate Ligament Reconstruction, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT02604550 is a Phase 4 study of Anterior Cruciate Ligament Reconstruction that has completed, run by Emory University. The registered enrollment target is 115 participants, below the 284-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02604550, a Phase 4 study of Anterior Cruciate Ligament Reconstruction, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to compare the pain control benefit of two different types of nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.
Conditions Studied
Interventions
- DRUG Ropivacaine 0.5%
- DRUG Percocet 7.5/325
- DRUG Naprosyn 500 mg
Study Locations (1)
Georgia
- Emory Healthcare Orthopaedics and Spine Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604550
The ClinicalTrials.gov registry entry for NCT02604550 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 11 other Anterior Cruciate Ligament Reconstruction trials with a reported enrollment target (60% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anterior Cruciate Ligament Reconstruction appearing as the primary indexed condition, and to 3 interventions - of which Ropivacaine 0.5% is the first listed.
NCT02604550 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02604550 about?
NCT02604550 is a clinical study titled "Anterior Cruciate Ligament Pain Study". The objective of this study is to compare the pain control benefit of two different types of nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.
What is the current status of trial NCT02604550?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 115 participants. The study started on 2015-11. Estimated completion is 2016-04.
What conditions does trial NCT02604550 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction.
What interventions are being tested in trial NCT02604550?
The interventions under investigation include: Ropivacaine 0.5% (DRUG), Percocet 7.5/325 (DRUG), Naprosyn 500 mg (DRUG).
Who is sponsoring clinical trial NCT02604550?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02604550 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
RECRUITING · Phase 4
-
Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction
COMPLETED · Phase 4
-
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
RECRUITING · Phase 2
-
Mental Imagery to Improve Quadriceps Strength Post Anterior Cruciate Ligament Reconstruction: a Feasibility Study
RECRUITING · NA
-
Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells
RECRUITING · Phase 1
-
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.